Fundz

Myricx Bio raised $114 million in a series A funding led by Novo Holdings and Abingworth to develop ADCs with a novel payload.

RECENTLY ACQUIREDJul 07, 2024

Amount Raised

$114 Million

Round Type

Series A

LondonBiotechnologyHealth Care

Investors

AbingworthNovo Holdings

Description

Myricx Bio, a UK start-up initially focused on small-molecule inhibitors, has secured a substantial cash runway with a record-breaking series A funding of £90 million ($114 million). The funding was led by life sciences investors Novo Holdings and Abingworth, showcasing confidence in Myricx Bio's approach and potential amidst the funding landscape for biotechs in the UK and Europe.

Quick answer

Myricx Bio raised $114 Million in a Series A round, dated July 7, 2024. Investors: Abingworth and Novo Holdings. Myricx Bio is based in London, England, United Kingdom.

How much did Myricx Bio raise?
Myricx Bio raised $114 Million in a Series A round on July 7, 2024.
Who invested in Myricx Bio?
Abingworth and Novo Holdings are named as investors in this round.
What does Myricx Bio do?
www.myricxbio.com Myricx Bio (“Myricx”) is a UK biotech company focused on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs), based on inhibitors of..
Where is Myricx Bio based and how big is it?
Myricx Bio is based in London, England, United Kingdom. Fundz records about 36 employees.
Who are the decision-makers at Myricx Bio?
Fundz holds 1 contact at Myricx Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Myricx Bio that raised within 45 days of this round, from Fundz verified event records.

  • Pathalys Pharma raised $105M (Series B) on August 21, 2024.
  • Superluminal Medicines raised $20M on August 21, 2024.
  • Piramidal raised $6M (Seed) on August 21, 2024.
  • Retension Pharmaceuticals raised $10M (Series A) on August 21, 2024.
  • David Protein raised $10M (Seed) on August 20, 2024.
  • Viome raised $25M on August 19, 2024.

Who to call at Myricx Bio, and when

A new round usually means Myricx Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Myricx Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Myricx Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Myricx Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Myricx Bio

Location

London, England, United Kingdom

About

www.myricxbio.com Myricx Bio (“Myricx”) is a UK biotech company focused on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer. NMT is an enzyme that adds a specific lipid modification to a number of protein targets key to cancer cell survival. Myricx is advancing a pipeline of ADCs to address serious unmet needs in oncology based on its NMT inhibitor (NMTi) payload chemistry platform and has demonstrated excellent preclinical efficacy and safety across multiple solid tumour associated antigens and cancer cell types. Based in London, Myricx is a spin out from Imperial College London and the Francis Crick Institute with investment from Sofinnova Partners and Brandon Capital Partners. Follow us on LinkedIn

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Myricx Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Myricx Bio's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Myricx Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.